Skip to content

Clinical trials

Phase 2 Venous Thromboembolism trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Venous Thromboembolism Phase: Phase 2 Country / region: Canada Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20062
20072
20091
20101
20111
20121
20132
20142
20151
20161
20172
20181
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ottawa Hospital Research Institute5
Bayer4
Boehringer Ingelheim3
Daiichi Sankyo2
Hamilton Health Sciences Corporation2
McMaster University2
Regeneron Pharmaceuticals2
GlaxoSmithKline1
Ionis Pharmaceuticals, Inc.1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Venous Thromboembolism23
Atrial Fibrillation4
Venous Thrombosis4
Hemorrhage2
Neoplasms2
Pulmonary Embolism2
Thromboembolism2
Heart Valve Diseases1
Ischemic Stroke1
Myeloproliferative Disorders1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.